Amalgamated Bank Has $3.55 Million Stock Holdings in ChampionX Co. (NASDAQ:CHX)

Amalgamated Bank reduced its stake in shares of ChampionX Co. (NASDAQ:CHXFree Report) by 3.0% during the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 121,666 shares of the company’s stock after selling 3,724 shares during the period. Amalgamated Bank’s holdings in ChampionX were worth $3,554,000 as of its most recent SEC filing.

Other institutional investors have also recently bought and sold shares of the company. Congress Asset Management Co. MA increased its position in shares of ChampionX by 114.0% during the third quarter. Congress Asset Management Co. MA now owns 4,172,230 shares of the company’s stock worth $148,615,000 after acquiring an additional 2,222,224 shares in the last quarter. FMR LLC increased its holdings in ChampionX by 20.2% during the 3rd quarter. FMR LLC now owns 7,109,432 shares of the company’s stock worth $253,238,000 after purchasing an additional 1,193,122 shares in the last quarter. Envestnet Asset Management Inc. raised its stake in shares of ChampionX by 136.8% in the 3rd quarter. Envestnet Asset Management Inc. now owns 1,022,461 shares of the company’s stock valued at $36,420,000 after purchasing an additional 590,680 shares during the period. Charles Schwab Investment Management Inc. lifted its holdings in shares of ChampionX by 28.5% in the third quarter. Charles Schwab Investment Management Inc. now owns 2,426,407 shares of the company’s stock valued at $86,429,000 after purchasing an additional 538,555 shares in the last quarter. Finally, Fort Washington Investment Advisors Inc. OH boosted its position in shares of ChampionX by 51.6% during the fourth quarter. Fort Washington Investment Advisors Inc. OH now owns 601,358 shares of the company’s stock worth $17,566,000 after buying an additional 204,640 shares during the period. Institutional investors own 98.99% of the company’s stock.

ChampionX Price Performance

NASDAQ:CHX opened at $34.22 on Friday. The stock has a market capitalization of $6.52 billion, a PE ratio of 18.60, a P/E/G ratio of 1.06 and a beta of 2.45. ChampionX Co. has a 1-year low of $24.98 and a 1-year high of $39.95. The firm has a fifty day simple moving average of $34.81 and a 200 day simple moving average of $31.17. The company has a current ratio of 1.83, a quick ratio of 1.16 and a debt-to-equity ratio of 0.35.

ChampionX (NASDAQ:CHXGet Free Report) last announced its quarterly earnings data on Wednesday, April 24th. The company reported $0.50 EPS for the quarter, beating analysts’ consensus estimates of $0.40 by $0.10. The company had revenue of $922.14 million during the quarter, compared to the consensus estimate of $922.13 million. ChampionX had a net margin of 9.74% and a return on equity of 21.42%. On average, research analysts expect that ChampionX Co. will post 1.95 EPS for the current fiscal year.

ChampionX Increases Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, April 26th. Stockholders of record on Friday, April 5th were given a $0.095 dividend. This represents a $0.38 dividend on an annualized basis and a dividend yield of 1.11%. This is a boost from ChampionX’s previous quarterly dividend of $0.09. The ex-dividend date was Thursday, April 4th. ChampionX’s dividend payout ratio (DPR) is presently 20.65%.

Analyst Upgrades and Downgrades

A number of equities research analysts recently issued reports on CHX shares. Piper Sandler lifted their target price on ChampionX from $32.00 to $40.00 and gave the company a “neutral” rating in a research report on Monday, April 8th. Citigroup boosted their price objective on shares of ChampionX from $39.00 to $40.00 and gave the stock a “buy” rating in a research report on Wednesday, March 27th. Finally, Barclays raised their target price on shares of ChampionX from $39.00 to $51.00 and gave the company an “overweight” rating in a research report on Thursday, April 4th. Two equities research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus target price of $40.33.

Check Out Our Latest Research Report on CHX

Insider Transactions at ChampionX

In other ChampionX news, insider William Jr. O’dell sold 27,178 shares of the firm’s stock in a transaction on Thursday, March 28th. The stock was sold at an average price of $36.00, for a total transaction of $978,408.00. Following the completion of the sale, the insider now owns 57,748 shares of the company’s stock, valued at approximately $2,078,928. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. 1.38% of the stock is currently owned by corporate insiders.

ChampionX Profile

(Free Report)

ChampionX Corporation provides chemistry solutions, artificial lift systems, and engineered equipment and technologies to oil and gas companies worldwide. The company operates through four segments: Production Chemical Technologies, Production & Automation Technologies, Drilling Technologies, and Reservoir Chemical Technologies.

Featured Articles

Want to see what other hedge funds are holding CHX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for ChampionX Co. (NASDAQ:CHXFree Report).

Institutional Ownership by Quarter for ChampionX (NASDAQ:CHX)

Receive News & Ratings for ChampionX Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ChampionX and related companies with MarketBeat.com's FREE daily email newsletter.